Cytovance Biologics Is A Biopharmaceutical Contract Manufacturing Company Based In Oklahoma Cityoklahomafounded In 2003 By Former Executives Of Novazyme Pharmaceuticalsthe Company Has Grown Significantlyespecially During The Early 2010Scytovance Specializes In Developing And Manufacturing Therapeutic Proteins And Antibodies For Biotechnology And Pharmaceutical Companies The Company Offers A Wide Range Of Servicesincluding Cell Line Developmentprocess Developmentanalytical Developmentand Both Clinical And Commercial Manufacturingcytovance Also Provides Regulatory Support To Help Clients Navigate Compliance And Submissionstheir Focus Is On Producing Large Molecule Active Pharmaceutical Ingredientsapisthrough Various Methodsincluding Mammalian Cell Culture And Microbial Fermentation Cytovance Operates From Advanced Facilities And Employs A Skilled Team Of Scientists And Engineersin 2015The Company Was Acquired By Hepalink Usaenhancing Its Capabilities And Growth Potential
United States
